BGAI
CPRX

Bruce G. Allen Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Bruce G. Allen Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23K Hold
39
– – ﹤0.01% 784
2026
Q1 		$966 Buy
39
+9
+30% +$214 ﹤0.01% 826
2025
Q4 		$700 Buy
30
+4
+15% +$89 ﹤0.01% 901
2025
Q3 		$512 Sell
26
-1
-4% -$21 ﹤0.01% 965
2025
Q2 		$586 Hold
27
– – ﹤0.01% 924
2025
Q1 		$655 Hold
27
– – ﹤0.01% 888
2024
Q4 		$563 Hold
27
– – ﹤0.01% 934
2024
Q3 		$537 Buy
+27
New +$501 ﹤0.01% 942

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bruce G. Allen Investments's CPRX Position: Q2 2026 in Review

Bruce G. Allen Investments held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 39 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #784.

Bruce G. Allen Investments first reported a position in CPRX in Q3 2024 and has held it in 8 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Bruce G. Allen Investments held 39 shares of Catalyst Pharmaceutical worth $1.23K as of Q2 2026.
  • Bruce G. Allen Investments left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #784 holding.
  • Bruce G. Allen Investments first reported a position in Catalyst Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.